Sanofi Pasteur may not charge the U.S. government more than other G7 countries for its coronavirus vaccine candidate, according to a redacted contract posted on HHS’ website. But unlike American taxpayers, Europeans did not fund the development of the vaccine. “Due to the exceptional and unprecedented nature of the COVID-19 threat to global public health and in recognition of the long historical partnership between the U.S. Government and Sanofi Pasteur working on global pandemic solutions, as well as the investments...